scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.BERH.2012.07.002 |
P698 | PubMed publication ID | 23040362 |
P2093 | author name string | Jacques Pouchot | |
Jean-Benoît Arlet | |||
P433 | issue | 4 | |
P304 | page(s) | 477-487 | |
P577 | publication date | 2012-08-01 | |
P1433 | published in | Best Practice & Research: Clinical Rheumatology | Q4896784 |
P1476 | title | Biological treatment in adult-onset Still's disease | |
P478 | volume | 26 |
Q53665027 | A woman with night sweats, arthritis, and two distinct eruptions. Adult-onset Still’s disease (AOSD). |
Q55375926 | Adding colchicine to immunosuppressive treatments; a potential option for biologics-refractory adult-onset Still's disease. |
Q37402329 | Adult Onset Still's Disease Associated with Mycoplasma pneumoniae Infection and Hemophagocytic Lymphohistiocytosis. |
Q33414045 | Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients |
Q89099286 | Application of Fluorine-18-Deoxyglucose Positron Emission Tomography and Gallium Scan for Assessment in a Patient With Adult-Onset Still's Disease |
Q49251571 | Biological therapy of traditional therapy-resistant adult-onset Still's disease: an evidence-based review. |
Q57300052 | Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease |
Q55109011 | Diagnostic and management of life-threatening Adult-Onset Still Disease: a French nationwide multicenter study and systematic literature review. |
Q64040568 | Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease |
Q53292199 | Fulminant myocarditis and macrophage activation syndrome secondary to adult-onset Still's disease successfully treated with tocilizumab. |
Q38635412 | Immunotherapeutic Biologic Agents in Autoimmune and Autoinflammatory Diseases |
Q33412732 | Life-threatening complications of adult-onset Still's disease |
Q36150742 | Myocarditis in adult-onset still disease |
Q38259728 | Pathophysiology and treatment of cardiac amyloidosis |
Q26830024 | Pathophysiology, subtypes, and treatments of adult-onset Still's disease: An update |
Q36427179 | Successful Treatment with Intravenous Cyclophosphamide for Refractory Adult-Onset Still's Disease |
Q40235629 | Tocilizumab for the treatment of adult-onset Still's disease: results from a case series. |
Q34043097 | Treatment of adult-onset Still's disease: a review |
Search more.